期刊文献+

新型降血糖药物介绍 被引量:1

下载PDF
导出
摘要 糖尿病是严重危害人类健康的三大疾病之一,本文简述几种新型降血糖药物马来酸罗格列酮、吡格列酮、瑞格列奈、那格列奈、格列本脲和盐酸二甲双胍复合片的药理及临床疗效。
出处 《海峡药学》 2005年第2期111-112,共2页 Strait Pharmaceutical Journal
  • 相关文献

参考文献3

二级参考文献13

  • 1Gomis R,Jones NP,Vallance SE,et al.Low-dose rosiglitazone enhance glycemic control when combined with sulphonylureas in type 2 diabetes[].Diabetologia.1999
  • 2Kreider M,Miller E,Patel J.Rosiglitazone is safe and well tolerated as monotherapy or combination therapy in patients with type 2 diabetes mellitus (T2DM)[].Diabetes.1999
  • 3Reiusset J,Auwerk J,Vidal H.Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone ( BRL 49563 ) in human adipocytes[].Biochemical and Biophysical Research Communications.1999
  • 4Salzman A.Rosiglitazone is not associated with hepatotoxicity[].Diabetologia.1999
  • 5Lebovitz HE,Patel J,Dole J,et al.Rosiglitazone (BRL 49653)monotherapy has significant glucose effect in type 2 diabetic patients[].Diabetologia.1998
  • 6Fonseca V,Biswas N,Salzmann A.Rosiglitazone in combination with metformin effectively reduces hyperglycemia in patients with type 2 diabetes[].Diabetologia.1999
  • 7Tabona MV,Weill S,Patwardhan R.Rosiglitazone given once or twice daily is effective first-line treatment for type 2 diabetes mellitus[].Diabetologia.1999
  • 8Raskin P,Dole JF,Rappaport EB.Rosiglitazone (RSG) improves glycemic conurol in poorly controlled, insulin-treated type 2 diabetes (T2D)[].Diabetes.1999
  • 9L¨O nnqvist F,Charbonnel B,Jones NP,et al.Rosiglitazone is superior to glibenclamide in reducing fasting plasma glucose in type 2 diabetic patients[].Diabetologia.1999
  • 10蒋伯诚.轻症糖尿病与胰岛素增敏剂和α-糖苷酶抑制剂[J].国外医药(合成药.生化药.制剂分册),1998,19(2):100-104. 被引量:14

共引文献43

同被引文献7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部